Table of Content

1 Longevity and Anti-Aging Drugs Market Overview
1.1 Product Overview and Scope of Longevity and Anti-Aging Drugs
1.2 Longevity and Anti-Aging Drugs Segment by Type
1.2.1 Global Longevity and Anti-Aging Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Calcium AKG Supplement
1.2.3 Nicotinamide Mononucleotide Supplement
1.2.4 Others
1.3 Longevity and Anti-Aging Drugs Segment by Application
1.3.1 Global Longevity and Anti-Aging Drugs Market Value by Application: (2024-2034)
1.3.2 Adult Male (Under 60 Years Old)
1.3.3 Adult Female (Under 60 Years Old)
1.3.4 Elderly (Above 60 Years Old)
1.4 Global Longevity and Anti-Aging Drugs Market Size Estimates and Forecasts
1.4.1 Global Longevity and Anti-Aging Drugs Revenue 2018-2029
1.4.2 Global Longevity and Anti-Aging Drugs Sales 2018-2029
1.4.3 Global Longevity and Anti-Aging Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Longevity and Anti-Aging Drugs Market Competition by Manufacturers
2.1 Global Longevity and Anti-Aging Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Longevity and Anti-Aging Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Longevity and Anti-Aging Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Longevity and Anti-Aging Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Longevity and Anti-Aging Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Longevity and Anti-Aging Drugs, Product Type & Application
2.7 Longevity and Anti-Aging Drugs Market Competitive Situation and Trends
2.7.1 Longevity and Anti-Aging Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Longevity and Anti-Aging Drugs Players Market Share by Revenue
2.7.3 Global Longevity and Anti-Aging Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Longevity and Anti-Aging Drugs Retrospective Market Scenario by Region
3.1 Global Longevity and Anti-Aging Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Longevity and Anti-Aging Drugs Global Longevity and Anti-Aging Drugs Sales by Region: 2018-2029
3.2.1 Global Longevity and Anti-Aging Drugs Sales by Region: 2018-2024
3.2.2 Global Longevity and Anti-Aging Drugs Sales by Region: 2024-2029
3.3 Global Longevity and Anti-Aging Drugs Global Longevity and Anti-Aging Drugs Revenue by Region: 2018-2029
3.3.1 Global Longevity and Anti-Aging Drugs Revenue by Region: 2018-2024
3.3.2 Global Longevity and Anti-Aging Drugs Revenue by Region: 2024-2029
3.4 North America Longevity and Anti-Aging Drugs Market Facts & Figures by Country
3.4.1 North America Longevity and Anti-Aging Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Longevity and Anti-Aging Drugs Sales by Country (2018-2029)
3.4.3 North America Longevity and Anti-Aging Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Longevity and Anti-Aging Drugs Market Facts & Figures by Country
3.5.1 Europe Longevity and Anti-Aging Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Longevity and Anti-Aging Drugs Sales by Country (2018-2029)
3.5.3 Europe Longevity and Anti-Aging Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Longevity and Anti-Aging Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Longevity and Anti-Aging Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Longevity and Anti-Aging Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Longevity and Anti-Aging Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Longevity and Anti-Aging Drugs Market Facts & Figures by Country
3.7.1 Latin America Longevity and Anti-Aging Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Longevity and Anti-Aging Drugs Sales by Country (2018-2029)
3.7.3 Latin America Longevity and Anti-Aging Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Longevity and Anti-Aging Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Longevity and Anti-Aging Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Longevity and Anti-Aging Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Longevity and Anti-Aging Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Longevity and Anti-Aging Drugs Sales by Type (2018-2029)
4.1.1 Global Longevity and Anti-Aging Drugs Sales by Type (2018-2024)
4.1.2 Global Longevity and Anti-Aging Drugs Sales by Type (2024-2029)
4.1.3 Global Longevity and Anti-Aging Drugs Sales Market Share by Type (2018-2029)
4.2 Global Longevity and Anti-Aging Drugs Revenue by Type (2018-2029)
4.2.1 Global Longevity and Anti-Aging Drugs Revenue by Type (2018-2024)
4.2.2 Global Longevity and Anti-Aging Drugs Revenue by Type (2024-2029)
4.2.3 Global Longevity and Anti-Aging Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Longevity and Anti-Aging Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Longevity and Anti-Aging Drugs Sales by Application (2018-2029)
5.1.1 Global Longevity and Anti-Aging Drugs Sales by Application (2018-2024)
5.1.2 Global Longevity and Anti-Aging Drugs Sales by Application (2024-2029)
5.1.3 Global Longevity and Anti-Aging Drugs Sales Market Share by Application (2018-2029)
5.2 Global Longevity and Anti-Aging Drugs Revenue by Application (2018-2029)
5.2.1 Global Longevity and Anti-Aging Drugs Revenue by Application (2018-2024)
5.2.2 Global Longevity and Anti-Aging Drugs Revenue by Application (2024-2029)
5.2.3 Global Longevity and Anti-Aging Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Longevity and Anti-Aging Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Vitality Pro
6.1.1 Vitality Pro Corporation Information
6.1.2 Vitality Pro Description and Business Overview
6.1.3 Vitality Pro Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Vitality Pro Longevity and Anti-Aging Drugs Product Portfolio
6.1.5 Vitality Pro Recent Developments/Updates
6.2 MoleQlar
6.2.1 MoleQlar Corporation Information
6.2.2 MoleQlar Description and Business Overview
6.2.3 MoleQlar Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.2.4 MoleQlar Longevity and Anti-Aging Drugs Product Portfolio
6.2.5 MoleQlar Recent Developments/Updates
6.3 Hansen Supplements
6.3.1 Hansen Supplements Corporation Information
6.3.2 Hansen Supplements Description and Business Overview
6.3.3 Hansen Supplements Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Hansen Supplements Longevity and Anti-Aging Drugs Product Portfolio
6.3.5 Hansen Supplements Recent Developments/Updates
6.4 Supplement Place
6.4.1 Supplement Place Corporation Information
6.4.2 Supplement Place Description and Business Overview
6.4.3 Supplement Place Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Supplement Place Longevity and Anti-Aging Drugs Product Portfolio
6.4.5 Supplement Place Recent Developments/Updates
6.5 Maxx Herb
6.5.1 Maxx Herb Corporation Information
6.5.2 Maxx Herb Description and Business Overview
6.5.3 Maxx Herb Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Maxx Herb Longevity and Anti-Aging Drugs Product Portfolio
6.5.5 Maxx Herb Recent Developments/Updates
6.6 Youth & Earth
6.6.1 Youth & Earth Corporation Information
6.6.2 Youth & Earth Description and Business Overview
6.6.3 Youth & Earth Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Youth & Earth Longevity and Anti-Aging Drugs Product Portfolio
6.6.5 Youth & Earth Recent Developments/Updates
6.7 Rejuvant LifeTabs
6.6.1 Rejuvant LifeTabs Corporation Information
6.6.2 Rejuvant LifeTabs Description and Business Overview
6.6.3 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Product Portfolio
6.7.5 Rejuvant LifeTabs Recent Developments/Updates
6.8 Renue By Science
6.8.1 Renue By Science Corporation Information
6.8.2 Renue By Science Description and Business Overview
6.8.3 Renue By Science Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Renue By Science Longevity and Anti-Aging Drugs Product Portfolio
6.8.5 Renue By Science Recent Developments/Updates
6.9 Double Wood Supplements
6.9.1 Double Wood Supplements Corporation Information
6.9.2 Double Wood Supplements Description and Business Overview
6.9.3 Double Wood Supplements Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Double Wood Supplements Longevity and Anti-Aging Drugs Product Portfolio
6.9.5 Double Wood Supplements Recent Developments/Updates
6.10 Quicksilver Scientific
6.10.1 Quicksilver Scientific Corporation Information
6.10.2 Quicksilver Scientific Description and Business Overview
6.10.3 Quicksilver Scientific Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Quicksilver Scientific Longevity and Anti-Aging Drugs Product Portfolio
6.10.5 Quicksilver Scientific Recent Developments/Updates
6.11 California Gold Nutrition
6.11.1 California Gold Nutrition Corporation Information
6.11.2 California Gold Nutrition Longevity and Anti-Aging Drugs Description and Business Overview
6.11.3 California Gold Nutrition Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.11.4 California Gold Nutrition Longevity and Anti-Aging Drugs Product Portfolio
6.11.5 California Gold Nutrition Recent Developments/Updates
6.12 ProHealth Longevity
6.12.1 ProHealth Longevity Corporation Information
6.12.2 ProHealth Longevity Longevity and Anti-Aging Drugs Description and Business Overview
6.12.3 ProHealth Longevity Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.12.4 ProHealth Longevity Longevity and Anti-Aging Drugs Product Portfolio
6.12.5 ProHealth Longevity Recent Developments/Updates
6.13 Peak Performance
6.13.1 Peak Performance Corporation Information
6.13.2 Peak Performance Longevity and Anti-Aging Drugs Description and Business Overview
6.13.3 Peak Performance Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Peak Performance Longevity and Anti-Aging Drugs Product Portfolio
6.13.5 Peak Performance Recent Developments/Updates
6.14 Do Not Age
6.14.1 Do Not Age Corporation Information
6.14.2 Do Not Age Longevity and Anti-Aging Drugs Description and Business Overview
6.14.3 Do Not Age Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Do Not Age Longevity and Anti-Aging Drugs Product Portfolio
6.14.5 Do Not Age Recent Developments/Updates
6.15 Nutriop
6.15.1 Nutriop Corporation Information
6.15.2 Nutriop Longevity and Anti-Aging Drugs Description and Business Overview
6.15.3 Nutriop Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Nutriop Longevity and Anti-Aging Drugs Product Portfolio
6.15.5 Nutriop Recent Developments/Updates
6.16 AFEGA Anti-Aging-Shop
6.16.1 AFEGA Anti-Aging-Shop Corporation Information
6.16.2 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Description and Business Overview
6.16.3 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.16.4 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Product Portfolio
6.16.5 AFEGA Anti-Aging-Shop Recent Developments/Updates
6.17 Xi'an Angel Biotechnology Co., Ltd.
6.17.1 Xi'an Angel Biotechnology Co., Ltd. Corporation Information
6.17.2 Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Description and Business Overview
6.17.3 Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Product Portfolio
6.17.5 Xi'an Angel Biotechnology Co., Ltd. Recent Developments/Updates
6.18 Longevity Box
6.18.1 Longevity Box Corporation Information
6.18.2 Longevity Box Longevity and Anti-Aging Drugs Description and Business Overview
6.18.3 Longevity Box Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Longevity Box Longevity and Anti-Aging Drugs Product Portfolio
6.18.5 Longevity Box Recent Developments/Updates
6.19 Age Science
6.19.1 Age Science Corporation Information
6.19.2 Age Science Longevity and Anti-Aging Drugs Description and Business Overview
6.19.3 Age Science Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Age Science Longevity and Anti-Aging Drugs Product Portfolio
6.19.5 Age Science Recent Developments/Updates
6.20 Nutravita
6.20.1 Nutravita Corporation Information
6.20.2 Nutravita Longevity and Anti-Aging Drugs Description and Business Overview
6.20.3 Nutravita Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Nutravita Longevity and Anti-Aging Drugs Product Portfolio
6.20.5 Nutravita Recent Developments/Updates
6.21 Aeternum
6.21.1 Aeternum Corporation Information
6.21.2 Aeternum Longevity and Anti-Aging Drugs Description and Business Overview
6.21.3 Aeternum Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Aeternum Longevity and Anti-Aging Drugs Product Portfolio
6.21.5 Aeternum Recent Developments/Updates
6.22 Toniiq
6.22.1 Toniiq Corporation Information
6.22.2 Toniiq Longevity and Anti-Aging Drugs Description and Business Overview
6.22.3 Toniiq Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Toniiq Longevity and Anti-Aging Drugs Product Portfolio
6.22.5 Toniiq Recent Developments/Updates
6.23 ProNutrition
6.23.1 ProNutrition Corporation Information
6.23.2 ProNutrition Longevity and Anti-Aging Drugs Description and Business Overview
6.23.3 ProNutrition Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.23.4 ProNutrition Longevity and Anti-Aging Drugs Product Portfolio
6.23.5 ProNutrition Recent Developments/Updates
6.24 Genex Formulas
6.24.1 Genex Formulas Corporation Information
6.24.2 Genex Formulas Longevity and Anti-Aging Drugs Description and Business Overview
6.24.3 Genex Formulas Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.24.4 Genex Formulas Longevity and Anti-Aging Drugs Product Portfolio
6.24.5 Genex Formulas Recent Developments/Updates
6.25 Physicians Longevity
6.25.1 Physicians Longevity Corporation Information
6.25.2 Physicians Longevity Longevity and Anti-Aging Drugs Description and Business Overview
6.25.3 Physicians Longevity Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.25.4 Physicians Longevity Longevity and Anti-Aging Drugs Product Portfolio
6.25.5 Physicians Longevity Recent Developments/Updates
6.26 AlphaFit
6.26.1 AlphaFit Corporation Information
6.26.2 AlphaFit Longevity and Anti-Aging Drugs Description and Business Overview
6.26.3 AlphaFit Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.26.4 AlphaFit Longevity and Anti-Aging Drugs Product Portfolio
6.26.5 AlphaFit Recent Developments/Updates
6.27 Lovita Foods
6.27.1 Lovita Foods Corporation Information
6.27.2 Lovita Foods Longevity and Anti-Aging Drugs Description and Business Overview
6.27.3 Lovita Foods Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.27.4 Lovita Foods Longevity and Anti-Aging Drugs Product Portfolio
6.27.5 Lovita Foods Recent Developments/Updates
6.28 Jarrow Formulas
6.28.1 Jarrow Formulas Corporation Information
6.28.2 Jarrow Formulas Longevity and Anti-Aging Drugs Description and Business Overview
6.28.3 Jarrow Formulas Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.28.4 Jarrow Formulas Longevity and Anti-Aging Drugs Product Portfolio
6.28.5 Jarrow Formulas Recent Developments/Updates
6.29 Body Union
6.29.1 Body Union Corporation Information
6.29.2 Body Union Longevity and Anti-Aging Drugs Description and Business Overview
6.29.3 Body Union Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
6.29.4 Body Union Longevity and Anti-Aging Drugs Product Portfolio
6.29.5 Body Union Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Longevity and Anti-Aging Drugs Industry Chain Analysis
7.2 Longevity and Anti-Aging Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Longevity and Anti-Aging Drugs Production Mode & Process
7.4 Longevity and Anti-Aging Drugs Sales and Marketing
7.4.1 Longevity and Anti-Aging Drugs Sales Channels
7.4.2 Longevity and Anti-Aging Drugs Distributors
7.5 Longevity and Anti-Aging Drugs Customers
8 Longevity and Anti-Aging Drugs Market Dynamics
8.1 Longevity and Anti-Aging Drugs Industry Trends
8.2 Longevity and Anti-Aging Drugs Market Drivers
8.3 Longevity and Anti-Aging Drugs Market Challenges
8.4 Longevity and Anti-Aging Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Longevity and Anti-Aging Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Longevity and Anti-Aging Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Longevity and Anti-Aging Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Longevity and Anti-Aging Drugs Sales (Tons) of Key Manufacturers (2018-2024)
Table 5. Global Longevity and Anti-Aging Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Longevity and Anti-Aging Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Longevity and Anti-Aging Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Longevity and Anti-Aging Drugs Average Price (US$/Ton) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Longevity and Anti-Aging Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Longevity and Anti-Aging Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Longevity and Anti-Aging Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Longevity and Anti-Aging Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Longevity and Anti-Aging Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Longevity and Anti-Aging Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Longevity and Anti-Aging Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Longevity and Anti-Aging Drugs Sales by Region (2018-2024) & (Tons)
Table 18. Global Longevity and Anti-Aging Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Longevity and Anti-Aging Drugs Sales by Region (2024-2029) & (Tons)
Table 20. Global Longevity and Anti-Aging Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Longevity and Anti-Aging Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Longevity and Anti-Aging Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Longevity and Anti-Aging Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Longevity and Anti-Aging Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Longevity and Anti-Aging Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Longevity and Anti-Aging Drugs Sales by Country (2018-2024) & (Tons)
Table 27. North America Longevity and Anti-Aging Drugs Sales by Country (2024-2029) & (Tons)
Table 28. North America Longevity and Anti-Aging Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Longevity and Anti-Aging Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Longevity and Anti-Aging Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Longevity and Anti-Aging Drugs Sales by Country (2018-2024) & (Tons)
Table 32. Europe Longevity and Anti-Aging Drugs Sales by Country (2024-2029) & (Tons)
Table 33. Europe Longevity and Anti-Aging Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Longevity and Anti-Aging Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Longevity and Anti-Aging Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Longevity and Anti-Aging Drugs Sales by Region (2018-2024) & (Tons)
Table 37. Asia Pacific Longevity and Anti-Aging Drugs Sales by Region (2024-2029) & (Tons)
Table 38. Asia Pacific Longevity and Anti-Aging Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Longevity and Anti-Aging Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Longevity and Anti-Aging Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Longevity and Anti-Aging Drugs Sales by Country (2018-2024) & (Tons)
Table 42. Latin America Longevity and Anti-Aging Drugs Sales by Country (2024-2029) & (Tons)
Table 43. Latin America Longevity and Anti-Aging Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Longevity and Anti-Aging Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Longevity and Anti-Aging Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Longevity and Anti-Aging Drugs Sales by Country (2018-2024) & (Tons)
Table 47. Middle East & Africa Longevity and Anti-Aging Drugs Sales by Country (2024-2029) & (Tons)
Table 48. Middle East & Africa Longevity and Anti-Aging Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Longevity and Anti-Aging Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Longevity and Anti-Aging Drugs Sales (Tons) by Type (2018-2024)
Table 51. Global Longevity and Anti-Aging Drugs Sales (Tons) by Type (2024-2029)
Table 52. Global Longevity and Anti-Aging Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Longevity and Anti-Aging Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Longevity and Anti-Aging Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Longevity and Anti-Aging Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Longevity and Anti-Aging Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Longevity and Anti-Aging Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Longevity and Anti-Aging Drugs Price (US$/Ton) by Type (2018-2024)
Table 59. Global Longevity and Anti-Aging Drugs Price (US$/Ton) by Type (2024-2029)
Table 60. Global Longevity and Anti-Aging Drugs Sales (Tons) by Application (2018-2024)
Table 61. Global Longevity and Anti-Aging Drugs Sales (Tons) by Application (2024-2029)
Table 62. Global Longevity and Anti-Aging Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Longevity and Anti-Aging Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Longevity and Anti-Aging Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Longevity and Anti-Aging Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Longevity and Anti-Aging Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Longevity and Anti-Aging Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Longevity and Anti-Aging Drugs Price (US$/Ton) by Application (2018-2024)
Table 69. Global Longevity and Anti-Aging Drugs Price (US$/Ton) by Application (2024-2029)
Table 70. Vitality Pro Corporation Information
Table 71. Vitality Pro Description and Business Overview
Table 72. Vitality Pro Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 73. Vitality Pro Longevity and Anti-Aging Drugs Product
Table 74. Vitality Pro Recent Developments/Updates
Table 75. MoleQlar Corporation Information
Table 76. MoleQlar Description and Business Overview
Table 77. MoleQlar Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 78. MoleQlar Longevity and Anti-Aging Drugs Product
Table 79. MoleQlar Recent Developments/Updates
Table 80. Hansen Supplements Corporation Information
Table 81. Hansen Supplements Description and Business Overview
Table 82. Hansen Supplements Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 83. Hansen Supplements Longevity and Anti-Aging Drugs Product
Table 84. Hansen Supplements Recent Developments/Updates
Table 85. Supplement Place Corporation Information
Table 86. Supplement Place Description and Business Overview
Table 87. Supplement Place Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 88. Supplement Place Longevity and Anti-Aging Drugs Product
Table 89. Supplement Place Recent Developments/Updates
Table 90. Maxx Herb Corporation Information
Table 91. Maxx Herb Description and Business Overview
Table 92. Maxx Herb Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 93. Maxx Herb Longevity and Anti-Aging Drugs Product
Table 94. Maxx Herb Recent Developments/Updates
Table 95. Youth & Earth Corporation Information
Table 96. Youth & Earth Description and Business Overview
Table 97. Youth & Earth Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 98. Youth & Earth Longevity and Anti-Aging Drugs Product
Table 99. Youth & Earth Recent Developments/Updates
Table 100. Rejuvant LifeTabs Corporation Information
Table 101. Rejuvant LifeTabs Description and Business Overview
Table 102. Rejuvant LifeTabs Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 103. Rejuvant LifeTabs Longevity and Anti-Aging Drugs Product
Table 104. Rejuvant LifeTabs Recent Developments/Updates
Table 105. Renue By Science Corporation Information
Table 106. Renue By Science Description and Business Overview
Table 107. Renue By Science Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 108. Renue By Science Longevity and Anti-Aging Drugs Product
Table 109. Renue By Science Recent Developments/Updates
Table 110. Double Wood Supplements Corporation Information
Table 111. Double Wood Supplements Description and Business Overview
Table 112. Double Wood Supplements Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 113. Double Wood Supplements Longevity and Anti-Aging Drugs Product
Table 114. Double Wood Supplements Recent Developments/Updates
Table 115. Quicksilver Scientific Corporation Information
Table 116. Quicksilver Scientific Description and Business Overview
Table 117. Quicksilver Scientific Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 118. Quicksilver Scientific Longevity and Anti-Aging Drugs Product
Table 119. Quicksilver Scientific Recent Developments/Updates
Table 120. California Gold Nutrition Corporation Information
Table 121. California Gold Nutrition Description and Business Overview
Table 122. California Gold Nutrition Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 123. California Gold Nutrition Longevity and Anti-Aging Drugs Product
Table 124. California Gold Nutrition Recent Developments/Updates
Table 125. ProHealth Longevity Corporation Information
Table 126. ProHealth Longevity Description and Business Overview
Table 127. ProHealth Longevity Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 128. ProHealth Longevity Longevity and Anti-Aging Drugs Product
Table 129. ProHealth Longevity Recent Developments/Updates
Table 130. Peak Performance Corporation Information
Table 131. Peak Performance Description and Business Overview
Table 132. Peak Performance Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 133. Peak Performance Longevity and Anti-Aging Drugs Product
Table 134. Peak Performance Recent Developments/Updates
Table 135. Do Not Age Corporation Information
Table 136. Do Not Age Description and Business Overview
Table 137. Do Not Age Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 138. Do Not Age Longevity and Anti-Aging Drugs Product
Table 139. Do Not Age Recent Developments/Updates
Table 140. Nutriop Corporation Information
Table 141. Nutriop Description and Business Overview
Table 142. Nutriop Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 143. Nutriop Longevity and Anti-Aging Drugs Product
Table 144. Nutriop Recent Developments/Updates
Table 145. AFEGA Anti-Aging-Shop Corporation Information
Table 146. AFEGA Anti-Aging-Shop Description and Business Overview
Table 147. AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 148. AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Product
Table 149. AFEGA Anti-Aging-Shop Recent Developments/Updates
Table 150. Xi'an Angel Biotechnology Co., Ltd. Corporation Information
Table 151. Xi'an Angel Biotechnology Co., Ltd. Description and Business Overview
Table 152. Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 153. Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Product
Table 154. Xi'an Angel Biotechnology Co., Ltd. Recent Developments/Updates
Table 155. Longevity Box Corporation Information
Table 156. Longevity Box Description and Business Overview
Table 157. Longevity Box Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 158. Longevity Box Longevity and Anti-Aging Drugs Product
Table 159. Longevity Box Recent Developments/Updates
Table 160. Age Science Corporation Information
Table 161. Age Science Description and Business Overview
Table 162. Age Science Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 163. Age Science Longevity and Anti-Aging Drugs Product
Table 164. Age Science Recent Developments/Updates
Table 165. Nutravita Corporation Information
Table 166. Nutravita Description and Business Overview
Table 167. Nutravita Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 168. Nutravita Longevity and Anti-Aging Drugs Product
Table 169. Nutravita Recent Developments/Updates
Table 170. Aeternum Corporation Information
Table 171. Aeternum Description and Business Overview
Table 172. Aeternum Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 173. Aeternum Longevity and Anti-Aging Drugs Product
Table 174. Aeternum Recent Developments/Updates
Table 175. Toniiq Corporation Information
Table 176. Toniiq Description and Business Overview
Table 177. Toniiq Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 178. Toniiq Longevity and Anti-Aging Drugs Product
Table 179. Toniiq Recent Developments/Updates
Table 180. ProNutrition Corporation Information
Table 181. ProNutrition Description and Business Overview
Table 182. ProNutrition Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 183. ProNutrition Longevity and Anti-Aging Drugs Product
Table 184. ProNutrition Recent Developments/Updates
Table 185. Genex Formulas Corporation Information
Table 186. Genex Formulas Description and Business Overview
Table 187. Genex Formulas Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 188. Genex Formulas Longevity and Anti-Aging Drugs Product
Table 189. Genex Formulas Recent Developments/Updates
Table 190. Physicians Longevity Corporation Information
Table 191. Physicians Longevity Description and Business Overview
Table 192. Physicians Longevity Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 193. Physicians Longevity Longevity and Anti-Aging Drugs Product
Table 194. Physicians Longevity Recent Developments/Updates
Table 195. AlphaFit Corporation Information
Table 196. AlphaFit Description and Business Overview
Table 197. AlphaFit Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 198. AlphaFit Longevity and Anti-Aging Drugs Product
Table 199. AlphaFit Recent Developments/Updates
Table 200. Lovita Foods Corporation Information
Table 201. Lovita Foods Description and Business Overview
Table 202. Lovita Foods Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 203. Lovita Foods Longevity and Anti-Aging Drugs Product
Table 204. Lovita Foods Recent Developments/Updates
Table 205. Jarrow Formulas Corporation Information
Table 206. Jarrow Formulas Description and Business Overview
Table 207. Jarrow Formulas Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 208. Jarrow Formulas Longevity and Anti-Aging Drugs Product
Table 209. Jarrow Formulas Recent Developments/Updates
Table 210. Body Union Corporation Information
Table 211. Body Union Description and Business Overview
Table 212. Body Union Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 213. Body Union Longevity and Anti-Aging Drugs Product
Table 214. Body Union Recent Developments/Updates
Table 215. Key Raw Materials Lists
Table 216. Raw Materials Key Suppliers Lists
Table 217. Longevity and Anti-Aging Drugs Distributors List
Table 218. Longevity and Anti-Aging Drugs Customers List
Table 219. Longevity and Anti-Aging Drugs Market Trends
Table 220. Longevity and Anti-Aging Drugs Market Drivers
Table 221. Longevity and Anti-Aging Drugs Market Challenges
Table 222. Longevity and Anti-Aging Drugs Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Longevity and Anti-Aging Drugs
Figure 2. Global Longevity and Anti-Aging Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Longevity and Anti-Aging Drugs Market Share by Type in 2022 & 2029
Figure 4. Calcium AKG Supplement Product Picture
Figure 5. Nicotinamide Mononucleotide Supplement Product Picture
Figure 6. Others Product Picture
Figure 7. Global Longevity and Anti-Aging Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Longevity and Anti-Aging Drugs Market Share by Application in 2022 & 2029
Figure 9. Adult Male (Under 60 Years Old)
Figure 10. Adult Female (Under 60 Years Old)
Figure 11. Elderly (Above 60 Years Old)
Figure 12. Global Longevity and Anti-Aging Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Longevity and Anti-Aging Drugs Market Size (2018-2029) & (US$ Million)
Figure 14. Global Longevity and Anti-Aging Drugs Sales (2018-2029) & (Tons)
Figure 15. Global Longevity and Anti-Aging Drugs Average Price (US$/Ton) & (2018-2029)
Figure 16. Longevity and Anti-Aging Drugs Report Years Considered
Figure 17. Longevity and Anti-Aging Drugs Sales Share by Manufacturers in 2022
Figure 18. Global Longevity and Anti-Aging Drugs Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Longevity and Anti-Aging Drugs Players: Market Share by Revenue in 2022
Figure 20. Longevity and Anti-Aging Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Longevity and Anti-Aging Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Longevity and Anti-Aging Drugs Sales Market Share by Country (2018-2029)
Figure 23. North America Longevity and Anti-Aging Drugs Revenue Market Share by Country (2018-2029)
Figure 24. United States Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Longevity and Anti-Aging Drugs Sales Market Share by Country (2018-2029)
Figure 27. Europe Longevity and Anti-Aging Drugs Revenue Market Share by Country (2018-2029)
Figure 28. Germany Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Longevity and Anti-Aging Drugs Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Longevity and Anti-Aging Drugs Revenue Market Share by Region (2018-2029)
Figure 35. China Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Longevity and Anti-Aging Drugs Sales Market Share by Country (2018-2029)
Figure 45. Latin America Longevity and Anti-Aging Drugs Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Longevity and Anti-Aging Drugs Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Longevity and Anti-Aging Drugs Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Longevity and Anti-Aging Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Longevity and Anti-Aging Drugs by Type (2018-2029)
Figure 55. Global Revenue Market Share of Longevity and Anti-Aging Drugs by Type (2018-2029)
Figure 56. Global Longevity and Anti-Aging Drugs Price (US$/Ton) by Type (2018-2029)
Figure 57. Global Sales Market Share of Longevity and Anti-Aging Drugs by Application (2018-2029)
Figure 58. Global Revenue Market Share of Longevity and Anti-Aging Drugs by Application (2018-2029)
Figure 59. Global Longevity and Anti-Aging Drugs Price (US$/Ton) by Application (2018-2029)
Figure 60. Longevity and Anti-Aging Drugs Value Chain
Figure 61. Longevity and Anti-Aging Drugs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed